Tenofovir alafenamide (Vemlidy) for the initial treatment of chronic hepatitis B may confer modestly higher rates of complete ...

Dr David Johnson selects his 10 highest-impact publications from 2025, which define new management standards across a broad spectrum of diseases.

Long-term follow-up of Taiwanese children with chronic hepatitis B virus (HBV) infection showed that 3.29% had HBV surface antigen (HBsAg) seroconversion after antiviral treatment while another 3.86% ...

New research shows resilience partially offsets financial toxicity and improves quality of life in patients with primary ...

Lupin Ltd has signed an exclusive licensing agreement with Neopharmed Gentili for rights to the Plasil brand in the ...

SMC officials announced the addition of Gastroenterologist Dr. Ryan Burkholder, who will provide monthly clinics, as well as ...

The 2024 report on China’s gastroenterology and digestive endoscopy, based on national databases, highlights increased early cancer detection, optimized care for priority diseases, and enhanced ...

It's time for Unwrapped 2025. Explore Gastroenterology's defining moments, our Word of the Year, and a challenging brain ...

CT BUZZ’s Mackenzie Maynard welcomed  Dr. Housein Waziz, a physician with MidState Gastroenterology Specialists,  for a timely conversation focusing on the ...

A multicenter study led by UC Davis Health has tested a new treatment designed to improve care for people with a rare liver ...

Patients with severe IBS had higher S-EDE-Q scores, and patients with IBS and clinically significant eating disorder symptoms ...

Retrospective studies link proton pump inhibitors to multiple conditions; however, careful analysis shows that causality ...